NANOVEU LIMITED — Capital/Financing Update 2021

Feb 14, 2021

==> picture [164 x 44] intentionally omitted <==

Nanoveu Limited U1, 18 Olive Street Subiaco WA 6008 +61 8 6244 9095 www.nanoveu.com

ASX RELEASE

15 February 2021 ASX: NVU

Exclusive UK Distribution Agreement

Highlights:

• Exclusive 12-month distribution agreement executed with CuVira for antiviral products in the United Kingdom

• While there are no product sale guarantees, the Agreement establishes the following purchase order targets to maintain exclusivity:

  • Month 1 – US$10,000

  • Month 3 – US$400,000

  • Month 12 – US$4,000,000

• The Agreement to renew following the 12-month period, subject to purchase order targets being satisfied

• CuVira is a newly established venture between two respected UK-businessmen with deep industry links

• Exclusive Agreement accelerates the availability and reach of Nanoshield products across the UK market

Nanoveu Limited (“Nanoveu” or the “Company”) is pleased to announce the Company has executed a 12-month exclusive distribution agreement (the Agreement) with CuVira Limited (CuVira) for Nanoveu’s products, including Nanoshield antiviral products, in the United Kingdom market.

The Agreement is effective immediately and incentivises sales through a series of purchase order targets. While the Company confirms that there are no guarantees of product sales, the purchase order targets have been established for the distributor to maintain exclusivity.

Nanoveu has selected CuVira as its exclusive distributor throughout the UK following an inquiry from the distributor. CuVira is a newly established venture between respected business partners Crerar Adams and Mike Tierney.

Mr Adams is a former British Skiing Olympian and founder of Fibre Optic Lighting International Limited, which supplies lighting solutions to major construction projects across the UK and Europe. Mr Tierney founded management consultancy, Fulcrum Development & Consulting Ltd in 2002, providing process improvement and organisational development solutions to organisations across the UK, North America, Europe, Middle East and Africa. Fulcrum was acquired by independent management consultancy group Pragmatique Ltd in 2007 and he has been an executive board member since this time. The well-established track-record between Messrs Adams and Tierney strongly positions CuVira for its launch into the UK.

While Nanoveu has distributed to UK previously, the Company believes the agreement marks a significant expansion of distribution capabilities throughout the region.

==> picture [164 x 44] intentionally omitted <==

The agreement will see CuVira vend a wide range of Nanoveu’s Nanoshield antiviral products, ranging from B2B commercial rolls to retail phone cases and screen covers (excluding distribution via Nanoveu’s Customskins vending machines), as well as door handle covers, medical PPE face shields and other applications of Nanoshield.

Following the agreement with CuVira, the Company has established a series of partnerships across major sales destinations. The Company holds distribution agreements across:

• Singapore

• Thailand

• Malaysia

• Australia

• New Zealand

• United Kingdom

Nanoveu intends to continue its strategy of establishing distribution partnerships in major markets, which enhance sales capabilities without having to deploy significant amounts of capital. In addition, Nanoveu continues to promote direct-to-consumer sales through its online sales portal (https://www.nanoshield.co/shop) and is pursuing additional B2B opportunities with a number of prospective organisations.

Nanoveu’s antiviral technology has been independently demonstrated to be a highly effective agent for the eradication of viruses. The technology has been proven to eliminate 99.99%[1] of OC43, a viral strain affecting humans that is also a surrogate for COVID-19, in 30 minutes. The antiviral protection has also been validated against other bacteria and viruses including e.Coli, Influenza A (subtype H3N2), and coronavirus MHV-A59[2] .

Commenting on the Agreement, Nanoveu Executive Chairman and CEO Alfred Chong said:

“Our distribution network continues to expand internationally and the agreement with CuVira significantly enhances our capacity to generate sales in the UK. It is exceptionally pleasing that this agreement was the result of an inquiry from CuVira expressing interest in our unique Nanoshield technology, demonstrating that we are building traction in major markets.”

- Ends -

This announcement has been authorised for release by Nanoveu’s Executive Chairman and CEO.

For further information, pleasecontact:Alfred ChongExecutive Chairman and CEOt: +65 6557 0155e: info@nanoveu.com	For media / investor enquiries,please contact:David Tasker / Alex BakerChapter One Advisorst: + 61 433 112 936 / +61 432 801 745e: dtasker@chapteroneadvisors.com.au

1 See announcements of 5 and 25 May 2020

2 See announcement of 15 April 2020

2/3

==> picture [164 x 44] intentionally omitted <==

Nanoveu Limited U1, 18 Olive Street Subiaco WA 6008 +61 8 6244 9095 www.nanoveu.com

About Nanoveu:

Nanoveu is an ASX-listed technology company developing a range of products for mobile phones and other digital displays. The Company’s wholly-owned, flagship product is its Nanoshield antiviral protection which is available in a variety of mobile phone screen covers, mobile phone cases and as a commercial film capable of being applied to a number of surfaces. The product is a clear plastic containing a layer of charged copper nanoparticles which have antiviral and antimicrobial properties. The product is commercially available and sold in a number of countries via Nanoveu’s channel partners. Nanoveu also produces EyeFly3DTM, which converts 2D digital displays into 3D without the need for 3D glasses and is currently available for Apple iPhones and Google Pixel 3 phones.

In addition, the Company is also developing the following products:

• Customskins: vending machines capable of precisely applying screen covers to mobile phones in just over a minute and with an alignment accuracy of 150 microns;

• EyeFyx: a vision correction solution under development using hardware and software to manipulate screen output; and

• Anti-reflective coating technology capable of being applied to mobile phones, tablets, automotive displays and other digital displays.